INTRODUCTION

ELOCON 0.001 OINTMENT contains Mometasone which belongs to the group of medicines called Topical Corticosteroids. ELOCON 0.001 OINTMENT is used in the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis. It is also used to treat scalp psoriasis and seborrheic dermatitis.

Psoriasis is a type of skin disease that causes skin rash with itchy, scaly patches which most commonly occurs on the knees, elbows, trunk and scalp. Atopic dermatitis is a skin condition which makes your skin red and itchy. Scalp psoriasis is a common skin disorder that makes skin raised, reddish, often scaly on the scalp which can either occur as a single patch or several patches on the scalp. Seborrheic dermatitis is a common skin condition that affects your scalp which is characterized by red, and scaly patches of skin and dandruff.

Avoid applying ELOCON 0.001 OINTMENT, if you have rosacea (a skin condition affecting the face), acne (pimples), skin atrophy (thinning of the skin), dermatitis (skin inflammation) around the mouth, genital itching, viral infections such as shingles, chickenpox (viral infection), ulcerated skin, and wounds.

Before applying ELOCON 0.001 OINTMENT, inform your doctor if you have kidney or liver disease. ELOCON 0.001 OINTMENT should be used in pregnant women only if it is clearly necessary. It is not recommended for use in breastfeeding women. Consult your doctor before applying ELOCON 0.001 OINTMENT.

The medicine is not recommended for use in children below 2 years of age. Consult your doctor before applying ELOCON 0.001 OINTMENT.

The most common side effects of using ELOCON 0.001 OINTMENT are mild to moderate pruritus (itchy skin), burning and stinging sensation of skin, folliculitis (a type of skin infection marked by inflamed hair follicles), dryness of skin, mild skin atrophy (thin-shiny appearing skin). Consult your doctor if any of these symptoms gets worse.

USES OF ELOCON 0.001 OINTMENT

Used to treat:

• inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as psoriasis and atopic dermatitis
• scalp psoriasis
• seborrhoeic dermatitis

HOW ELOCON 0.001 OINTMENT WORKS

ELOCON 0.001 OINTMENT works by reducing the inflammation of skin by blocking the production of a chemical messenger which is responsible for causing red, swollen and itchy skin that occurs due to an allergic reaction or irritation in the skin thereby providing relief from the symptoms of psoriasis, atopic dermatitis, scalp psoriasis and seborrhoeic dermatitis.

DIRECTIONS FOR USE

Always apply ELOCON 0.001 OINTMENT as directed by your physician. It is for external use only. On the affected area, apply a thin layer of this medicine and gently rub into the affected area of skin. Treated areas on the face need not be covered with a plaster or bandage. Avoid applying the medicine around your eyes, including eyelids.

SIDE EFFECTS OF ELOCON 0.001 OINTMENT

HOW TO MANAGE SIDE EFFECTS

Dry Skin:

Try moisturizing your skin with an ointment, cream, or lotion 2 or 3 times a day, or as often as needed. Moisturizers help to keep the area moisture, so they work best on damp skin. After you bathe, pat your skin dry then apply your moisturizer. Try to avoid using skin care products and soaps that contain alcohol, fragrances, dyes, or other chemicals.

WARNING & PRECAUTIONS

INTERACTIONS

A. Drug-Drug interactions:

Before applying ELOCON 0.001 OINTMENT, inform your doctor, if you are applying or taking any of the prescription, non-prescription medicines and herbal supplements.

Overdosage:

If you or anyone else accidentally uses too much of ELOCON 0.001 OINTMENT, consult your doctor immediately or visit the nearby hospital.

SYNOPSIS

MORE INFORMATION

• Keep ELOCON 0.001 OINTMENT out of reach in children
• Store ELOCON 0.001 OINTMENT at room temperature

FAQs ABOUT ELOCON 0.001 OINTMENT

What ELOCON 0.001 OINTMENT is used for?

ELOCON 0.001 OINTMENT is used in the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis. It is also used to treat scalp psoriasis and seborrheic dermatitis.

What happens if you suddenly stop using ELOCON 0.001 OINTMENT?

If you have been applying ELOCON 0.001 OINTMENT for a long time and your skin problem seems to have got better, you should not suddenly stop using the medicine. If you do, you may find that your skin becomes red and may notice a stinging or burning sensation. To avoid this, consult and discuss with your doctor before stopping ELOCON 0.001 OINTMENT.

Who should avoid applying ELOCON 0.001 OINTMENT?

ELOCON 0.001 OINTMENT is not recommended for use in patients allergic to Mometasone, and/or have conditions such as rosacea, acne, skin atrophy, dermatitis around the mouth, cold sores, shingles or chickenpox (viral infection), ulcerated skin, and wounds.

What are the common side effects of ELOCON 0.001 OINTMENT?

The most common side effects of using ELOCON 0.001 OINTMENT are mild to moderate pruritus (itchy skin), burning and stinging sensation of skin, folliculitis, dryness of skin, mild skin atrophy (thin-shiny appearing skin) and temporary burning sensation on the site of application. Consult your doctor if any of these symptoms gets worse.

How ELOCON 0.001 OINTMENT should be applied on the site of infection?

It is for external use only. On the affected area, apply a thin layer of this medicine. Treated areas on the face need not be covered with a plaster or bandage. Do not apply ELOCON 0.001 OINTMENT on your face beyond 5 days. Avoid applying the medicines around your eyes, including eyelids.

REFERENCES

1. KD. Tripathi. Drugs Acting on Skin & Mucous Membranes. Essentials of medical pharmacology. Seventh edition. 2013. Page – 895.

2. Seanergy Dermatology Ltd. Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects. (SNG100). NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in November 2020] [Accessed on 24th May 2022] https://clinicaltrials.gov/ct2/show/NCT04615962

3. Fabrizio Spada, Tanya M Barnes, and Kerryn A Greive. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids. NIH National Library of Medicine, National center for biotechnology information. PMC PubMed Central. February 2018 [Accessed on 24th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099284/

4. Wei Xu, Yan Li, Mei Ju, Wei Lai, Xueyan Lu, Huijuan Shi, 5 Weimin Shi, 6 Heng Gu, and Linfeng Li. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Compound Glycyrrhizin Capsules Combined with a Topical Corticosteroid in Adults with Chronic Eczema. NIH National Library of Medicine, National center for biotechnology information. PMC PubMed Central. March 2020 [Accessed on 24th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149328/

5. Glenmark Pharmaceuticals s.r.o. Electronic medicines compendium (EMC). [Revised in January 2022] [Accessed on 24th May 2022] https://www.medicines.org.uk/emc/files/pil.9994.pdf

6. Salutas Pharma GmbH. Electronic medicines compendium (EMC). [Revised in January 2022] [Accessed on 24th May 2022] https://www.medicines.org.uk/emc/files/pil.9996.pdf

7. Organon (New Zealand) Limited. New Zealand Medicines and Medical devices Safety Authority (medsafe). [Revised in January 2020]  [Accessed on 24th May 2022] https://www.medsafe.govt.nz/profs/Datasheet/e/Eloconcrointlot.pdf

8. Torrent Pharmaceuticals. [Revised in July 2020]  [Accessed on 24th May 2022] https://www.torrentian.com/pisheet/Search.aspx